Frederik Vandenberghe

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


47 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
2024
 
Antihistaminiques : une histoire sans fin [Antihistamines : An ongoing narrative]
Vandenberghe-Dürr S., Harr T., Vandenberghe F., 2024/04/03. Revue medicale suisse, 20 (868) pp. 711-719. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_58EED2EB95DA]
2023
 
Use of pharmacological treatment for posttraumatic stress disorder: Analysis of a psychiatric population in Switzerland and comparison with international guidelines.
Montavon F., Vandenberghe F., Eap C.B., 2023/10. L'Encephale, 49 (5) pp. 446-452. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29F467041DCE]
 
Prescription d’antipsychotiques chez les adultes : à quoi faut-il être attentif ? [Antipsychotic prescribing in adults : what to watch out for ?]
Grandjean C., Vandenberghe F., Dubath C., Sibailly G., Ansermot N., Crettol Wavre S., Eap C.B., 2023/09/20. Revue medicale suisse, 19 (842) pp. 1707-1712. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A5F7D63D1926]
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.
Sjaarda J., Delacrétaz A., Dubath C., Laaboub N., Piras M., Grosu C., Vandenberghe F., Crettol S., Ansermot N., Gamma F. et al., 2023/06. Molecular psychiatry, 28 (6) pp. 2320-2327. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC34831410AA]
The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants.
Garin P., Favre L., Vionnet N., Frantz J., Eap C.B., Vandenberghe F., 2023/05. Obesity surgery, 33 (5) pp. 1422-1430. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EDCDCEA08158]
2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
Perry B.I., Vandenberghe F., Garrido-Torres N., Osimo E.F., Piras M., Vazquez-Bourgon J., Upthegrove R., Grosu C., De La Foz V.O., Jones P.B. et al., 2022/11. The Lancet regional health. Europe, 22 p. 100493. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A56B7AE8F057]
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
Laaboub N., Dubath C., Ranjbar S., Sibailly G., Grosu C., Piras M., Délessert D., Richard-Lepouriel H., Ansermot N., Crettol S. et al., 2022/05/17. BMC psychiatry, 22 (1) p. 342. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E9824076089]
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
Schoretsanitis G., Dubath C., Grosu C., Piras M., Laaboub N., Ranjbar S., Ansermot N., Crettol S., Vandenberghe F., Gamma F. et al., 2022/04. Basic & clinical pharmacology & toxicology, 130 (4) pp. 531-541. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_995572119F81]
Le liraglutide a-t-il sa place en psychiatrie ? [Does liraglutide have a place in psychiatry ?]
Frantz J., Favre L., Vandenberghe F., 2022/03/23. Revue medicale suisse, 18 (774) pp. 522-526. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_260924C7B8AF]
2021
Gabapentinoïdes : mésusages et addictions [Gabapentinoids : misuses and addictions]
Grandjean C., Crettol Wavre S., Khazaal Y., Sanchis Zozaya J., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/12/15. Revue medicale suisse, 17 (763) pp. 2206-2208. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CADF3E9C3F84]
Recommandations de prise en charge des mésusages et addictions aux benzodiazepines [Recommendations for management of misuses and addictions to benzodiazepines]
Grandjean C., Crettol Wavre S., Khazaal Y., Sanchis Zozaya J., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/10/13. Revue medicale suisse, 17 (754) pp. 1754-1759. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5EEA6C9D3688]
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
Eap C.B., Gründer G., Baumann P., Ansermot N., Conca A., Corruble E., Crettol S., Dahl M.L., de Leon J., Greiner C. et al., 2021/10. The world journal of biological psychiatry, 22 (8) pp. 561-628. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6FD14CC75A02]
 
Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology.
Javelot H., Gitahy Falcao Faria C., Vandenberghe F., Dizet S., Langrée B., Le Maout M., Straczek C., Egron A., Erb A., Sujol G. et al., 2021/08/21. Pharmacy, 9 (3) p. 146. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_013702055D1E]
Benzodiazépines, addiction et autorisation cantonale : cadre juridique et implications cliniques [Benzodiazepines, addiction and cantonal authorization : legal framework and clinical implications.]
Junod V., Baud C.A., Broers B., Vandenberghe F., Simon O., 2021/06/09. Revue medicale suisse, 17 (742) pp. 1115-1117.
[URN][DOI][Pmid][serval:BIB_812B42B72B9F]
Traitement de l’insomnie, par quoi commencer ? [Treatment of insomnia, with what to start ?]
Grandjean C., Crettol Wavre S., Ansermot N., Vandenberghe F., Sibailly G., Eap C.B., 2021/05/05. Revue medicale suisse, 17 (737) pp. 890-897. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_44F7FFE9FAFC]
Bioavailability of Vortioxetine After a Roux-en-Y Gastric Bypass.
Vandenberghe F., Gilet P., Daali Y., Favre L., Eap C.B., 2021/03. Obesity surgery, 31 (3) pp. 1353-1356. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_519FDF490519]
Psychiatrie [Psychiatry]
Khazaal Y., Elowe J., Kloucek P., Preisig M., Tadri M., Vandeleur C., Vandenberghe F., Verloo H., Ros T., Von Gunten A., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 85-89.
[URN][DOI][Pmid][serval:BIB_29A1AD3D1683]
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort.
Laaboub N., Gholam M., Sibailly G., Sjaarda J., Delacrétaz A., Dubath C., Grosu C., Piras M., Ansermot N., Crettol S. et al., 2021. Frontiers in psychiatry, 12 p. 756403. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C84BB0F598EF]
Psychiatrie [Psychiatry]
Khazaal Yasser, Elowe Julien, Kloucek Petr, Preisig Martin, Tadri Myriam, Vandeleur Caroline, Vandenberghe Frederik, Verloo Henk, Ros Tomas, Von Guntenb Armin, 2021. Revue Médicale Suisse, 17 (720-21) pp. 85-89. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2FF23DAE8BCF]
2020
Agitation aiguë chez l’adulte : proposition d’un algorithme de traitement psychopharmacologique [Rapid tranquilisation in adults : algorithm proposed for psychopharmacological treatment]
Crettol Wavre S., Ansermot N., Sibailly G., Vandenberghe F., Grandjean C., Teixeira Robalo B., Fassassi Gallo S., Thonney J., Solida-Tozzi A., Conus P. et al., 2020/09/23. Revue medicale suisse, 16 (707) pp. 1751-1755. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7B77DD272619]
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication.
Alameda L., Levier A., Gholam-Rezaee M., Golay P., Vandenberghe F., Delacretaz A., Baumann P., Glatard A., Dubath C., Herane-Vives A. et al., 2020. PloS one, 15 (12) pp. e0242569. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9615E0192FAB]
2019
 
Impact of drugs on hypoglycaemia in hospitalised patients.
Vandenberghe F., Challet C., Maitrejean M., Christin L., Schaad N., 2019/07. European journal of hospital pharmacy, 26 (4) pp. 199-204. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5F938DC2AEF0]
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset Hypercholesterolemia.
Delacrétaz A., Vandenberghe F., Glatard A., Dubath C., Levier A., Gholam-Rezaee M., Holzer L., Ambresin A.E., Conus P., Eap C.B., 2019/04/09. The Journal of clinical psychiatry, 80 (3). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B98038AE6722]
Chirurgie bariatrique et psychotropes: où en sommes-nous? [Bariatric surgery and psychotropic drugs : where are we now ?]
Vandenberghe F., Corminboeuf Y., Favre L., 2019/03/20. Revue medicale suisse, 15 (643) pp. 631-635. Peer-reviewed.
[DOI][Pmid][serval:BIB_99C3422E5AD0]
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
Quteineh L., Wójtowicz A., Bochud P.Y., Crettol S., Vandenberghe F., Venetz J.P., Manuel O., Golshayan D., Lehmann R., Mueller N.J. et al., 2019/01. American journal of transplantation, 19 (1) pp. 238-246. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6D920C4CDD77]
2018
Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
Delacrétaz Aurélie, Vandenberghe Frederik, Glatard Anaïs, Levier Axel, Dubath Céline, Ansermot Nicolas, Crettol Séverine, Gholam-Rezaee Mehdi, Guessous Idris, Bochud Murielle et al., 2018/11/09. Frontiers in Psychiatry, 9.
[URN][DOI][WoS][Pmid][serval:BIB_EFD90D5BB70B]
Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain.
Vandenberghe F., Najar-Giroud A., Holzer L., Conus P., Eap C.B., Ambresin A.E., 2018/05. Journal of child and adolescent psychopharmacology, 28 (4) pp. 258-265. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E2606312F994]
Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.
Delacrétaz A., Vandenberghe F., Gholam-Rezaee M., Saigi Morgui N., Glatard A., Thonney J., Solida-Tozzi A., Kolly S., Gallo S.F., Baumann P. et al., 2018. Journal of clinical lipidology, 12 (1) pp. 219-229. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B3A7B269E9CC]
2017
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs.
Delacrétaz A., Lagares Santos P., Saigi Morgui N., Vandenberghe F., Glatard A., Gholam-Rezaee M., von Gunten A., Conus P., Eap C.B., 2017/12. Pharmacogenetics and genomics, 27 (12) pp. 464-472. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FB1D5A1CCA6F]
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.
Delacrétaz A., Zdralovic A., Vandenberghe F., Saigi-Morgui N., Glatard A., Quteineh L., Gholam-Rezaee M., Raffoul W., Applegate L.A., Jafari P. et al., 2017/09/10. Gene, 628 pp. 8-15. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B119BA2C151]
 
Association of genetic risk scores with body mass index in Swiss psychiatric cohorts
Saigi-Morgui Nuria, Vandenberghe Frederik, Delacrétaz Aurélie, Quteineh Lina, Gholamrezaee Mehdi, Kutalik Zoltan, Aubry Jean Michel, von Gunten Armin, Conus Philippe, Eap Chin B., 2017., 23rd Annual world congress of Psychiatric Genetics (WCPG), Toronto, Canada pp. S248 dans European Neuropsychopharmacology, Elsevier BV.
[DOI][serval:BIB_F48AF55AFB3A]
2016
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
Vandenberghe F., Saigí-Morgui N., Delacrétaz A., Quteineh L., Crettol S., Ansermot N., Gholam-Rezaee M., von Gunten A., Conus P., Eap C.B., 2016/12. Pharmacogenetics and genomics, 26 (12) pp. 547-557. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BFD29890FF60]
Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression.
Quteineh L., Preisig M., Rivera M., Milaneschi Y., Castelao E., Gholam-Rezaee M., Vandenberghe F., Saigi-Morgui N., Delacrétaz A., Cardinaux J.R. et al., 2016/07/01. Journal of affective disorders, 198 pp. 43-49. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB055B9E66F0]
 
Psychiatrie [New developments in psychiatry]
Conus P., Herrera F., Berney S., Gailland B., Beretta V., Vandenberghe F., Eap C.B., 2016/01/13. Revue medicale suisse, 12 (500) pp. 86-89. Peer-reviewed.
[Pmid][serval:BIB_6F65192527D5]
Association of genetic risk scores with body mass index in Swiss psychiatric cohorts.
Saigi-Morgui N., Vandenberghe F., Delacrétaz A., Quteineh L., Gholamrezaee M., Aubry J.M., von Gunten A., Kutalik Z., Conus P., Eap C.B., 2016. Pharmacogenetics and Genomics, 26 (5) pp. 208-217. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3012FE323A7B]
2015
 
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients with psychotropic treatments
Quteineh L., Vandenberghe F., Saigi Morgui N., Delacretaz A., Choong E., Gholam-Rezaee M., Magistretti P., Bondolfi G., von Gunten A., Preisig M. et al., 2015/06. dans 12th World Congress of Biological Psychiatry, Athens, Greece, June 14-18, 2015.
[serval:BIB_3618F8958220]
 
Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in subjects from the general population with present or past atypical depression
Choong E., Delacretaz A., Preisig M., Vandenberghe F., Saigi Morgui N., Quteineh L., Gholam-Rezaee M., Kutalik Z., Castelao P., Aubry J.-M. et al., 2015/06. dans 12th World congress of Biological Psychiatry (WFSBP)- 14 – 18 june 2015 - Athens, Greece.
[serval:BIB_1BAEC4811834]
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments.
Saigi-Morgui N., Vandenberghe F., Delacrétaz A., Quteineh L., Choong E., Gholamrezaee M., Magistretti P., Aubry J.M., von Gunten A., Preisig M. et al., 2015. Journal of Clinical Psychopharmacology, 35 (5) pp. 544-552. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_65A415095D9E]
Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort.
Vandenberghe F., Guidi M., Choong E., von Gunten A., Conus P., Csajka C., Eap C.B., 2015. Clinical Pharmacokinetics, 54 (12) pp. 1259-1272. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_594496D78157]
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
Quteineh L., Vandenberghe F., Saigi Morgui N., Delacrétaz A., Choong E., Gholam-Rezaee M., Magistretti P., Bondolfi G., Von Gunten A., Preisig M. et al., 2015. Pharmacogenetics and Genomics, 25 (5) pp. 246-258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_361B0D4F6D36]
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
Vandenberghe F., Gholam-Rezaee M., Saigí-Morgui N., Delacrétaz A., Choong E., Solida-Tozzi A., Kolly S., Thonney J., Gallo S.F., Hedjal A. et al., 2015. Journal of Clinical Psychiatry, 76 (11) pp. e1417-e1423. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3DE3D0341247]
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression.
Delacrétaz A., Preisig M., Vandenberghe F., Saigi Morgui N., Quteineh L., Choong E., Gholam-Rezaee M., Kutalik Z., Magistretti P., Aubry J.M. et al., 2015. Plos One, 10 (10) pp. e0139155. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_200412067B84]
2014
 
CRTC3 Polymorphisms are not associated with obesity in swiss psychiatric populations
Quteineh L, Vandenberghe F, Rezaee MG, Choong E, Morgui NS, Delacretaz A, Preisig M, Von Gunten A, Conus P, Eap C., 2014. dans European Psychiatry. Peer-reviewed.
[DOI][serval:BIB_21280335216B]
 
CRTC3 POLYMORPHISMS ARE NOT ASSOCIATED WITH OBESITY IN SWISS PSYCHIATRIC POPULATIONS
Quteineh L., Vandenberghe F., Rezaee M. G., Choong E., Morgui N. S., Delacretaz A., Preisig M., Von Gunten A., Conus P., Eap C., 2014., chuv.
[WoS][serval:BIB_11D721FCFAEB]
 
Predictive values of apetite and early weight increase for long-term weight variation during psychotropic treatment
Vandenberghe F, Rezaee MG, Choong E, Morgui NS, Delacretaz A, Preisig M, Von Gunten A, Conus P, Eap C., 2014. dans European Psychiatry. Peer-reviewed.
[DOI][WoS][serval:BIB_2A8C03791C10]
2013
Influence of CRTC1 Polymorphisms on Body Mass Index and Fat Mass in Psychiatric Patients and the General Adult Population.
Choong E., Quteineh L., Cardinaux J.R., Gholam-Rezaee M., Vandenberghe F., Dobrinas M., Bondolfi G., Etter M., Holzer L., Magistretti P. et al., 2013. JAMA Psychiatry, 70 (10) pp. 1011-1019. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1BC1C0DFA15B]
2012
 
Clinical and pharmacogenetic study on psychotropic drug induced weight gain and other metabolic complications in a Swiss psychiatric population
Eap C, Vandenberghe F, Choong Eva, Ambresin A, Von Gunten A, Conus P, 2012. dans International Journal of Neuropsychopharmacology.
[WoS][serval:BIB_CCAD682D642D]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University